Publications by authors named "Amanda K Irish"
Article Synopsis
- Emerging evidence suggests dietary interventions may improve outcomes for multiple sclerosis (MS), but limited data exists on how they affect functional disability.
- A study pooled data from two 12-week trials to assess the impact of a modified Paleolithic diet (Paleo) on functional disability in MS patients, measuring outcomes with the MS Functional Composite (MSFC).
- The results indicated that while there was no significant overall difference between the Paleo and Control groups, the Paleo group showed reduced functional disability over time, particularly in specific tests, highlighting potential benefits linked to this diet for certain types of MS.
Background: A serosurvey of healthy blood donors provided evidence of hemorrhagic fever and arthropod-borne virus infections in Uganda.
Methods: Antibody prevalence to arthropod-borne and hemorrhagic fever viruses in human sera was determined using enzyme-linked immunosorbent assay (ELISA) and plaque reduction neutralization test (PRNT).
Results: The greatest antibody prevalence determined by ELISA was to chikungunya virus (CHIKV) followed in descending order by West Nile virus (WNV), Crimean-Congo hemorrhagic fever virus (CCHFV), Ebola virus (EBOV), dengue virus (DEN), yellow fever virus (YFV), Rift Valley fever virus (RVFV), Marburg virus (MARV), and Lassa virus (LASV).
Background/objective: A Paleolithic diet may improve fatigue and quality of life in progressive multiple sclerosis (MS) patients, but past research has evaluated the effects of this dietary intervention in combination with other treatments such as exercise. Thus, the purpose of this pilot study was to evaluate a modified Paleolithic dietary intervention (MPDI) in the treatment of fatigue and other symptoms in relapsing-remitting MS (RRMS).
Methods: We measured the effects of a MPDI in 17 individuals with RRMS.